SINTX Technologies Inc
NASDAQ:SINT
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
SINTX Technologies Inc
NASDAQ:SINT
|
10.7m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.4B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.4B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
140B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
127.3B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.9B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.8B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.2B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.5B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.6B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
SINTX Technologies Inc
Glance View
SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. The company is headquartered in Salt Lake City, Utah and currently employs 36 full-time employees. The company went IPO on 2014-02-11. The firm is focused on manufacturing, research and development of silicon nitride ceramics for external partners. The firm's medical-grade silicon nitride products includes FleX SN-MC2, FleX SN-CSC, FleX SN-PEEK and FleX SN-AP, which are biocompatible, bioactive, antipathogenic and has a bone affinity. The firm's antipathogenic product, FleX SN-AP, which is a silicon nitride antipathogenic powder used in manufacturing of products such as face masks and personal protective equipment. The firm's non-medical applications are used in manufacturing of ceramic armors for the aerospace and defense industries. Its industrial silicon nitride has a combination of mechanical, thermal and electrical properties of any technical ceramic material.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for SINTX Technologies Inc is 52%, which is below its 3-year median of 70.9%.
Over the last 3 years, SINTX Technologies Inc’s Gross Margin has decreased from 62.5% to 52%. During this period, it reached a low of 52% on Sep 30, 2025 and a high of 85.2% on Sep 30, 2023.
